(3) Conclusions: In the case of our patient, polycythemia vera represented a predisposing risk factor for CVT, and the identification of <i>JAK2 V617F</i> mutation was mandatory for the etiology of the disease. The gene discussed is JAK2; the disease is acquired polycythemia vera.